APA (7th ed.) Citation

Wang, X., Tang, X., Gu, J., Sun, Z., Yang, S., Mu, Y., . . . Xu, J. (2023). CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma. Cancer Medicine, 12(4), 4521. https://doi.org/10.1002/cam4.5221

Chicago Style (17th ed.) Citation

Wang, Xueying, et al. "CEACAM6 Serves as a Biomarker for Leptomeningeal Metastasis in Lung Adenocarcinoma." Cancer Medicine 12, no. 4 (2023): 4521. https://doi.org/10.1002/cam4.5221.

MLA (9th ed.) Citation

Wang, Xueying, et al. "CEACAM6 Serves as a Biomarker for Leptomeningeal Metastasis in Lung Adenocarcinoma." Cancer Medicine, vol. 12, no. 4, 2023, p. 4521, https://doi.org/10.1002/cam4.5221.